Is it growing?
Is INDV growing?
Indivior Pharmaceuticals, Inc. has grown revenue 11% a year over three years and 11% a year over five.
+11%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from fiscal-year columns as filed
- Revenue growth, 5-year rate
- +11%
Revenue growth, 5-year rate · +11% over three · growth has slowed since the five-year average
- Years of annual history on file
- 4
Years of annual history on file · FY2022 to FY2025, as filed
Details›
- Revenue FY2022
- $901M
- Revenue FY2023
- $1.09B
- Revenue FY2024
- $1.19B
- Revenue FY2025
- $1.24B
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #23 of 28 by Smart Score